
Neurogene Reports Inducement Equity Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
Neurogene Announces Inducement Equity Grants Under Nasdaq Listing Rule 5635(c)(4) Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company committed to developing life-changing genetic medicines for individuals and families affected by…












